Dr. Stefan Gross
Thursday, November 2, 2017
Agios Pharmaceuticals
Director, Enzymology
"Treatment of Rare Genetic Diseases by Small Molecule Allosteric Activators"
11:30 a.m.
LSL S330/340
Host:
Mike Knapp
"Treatment of Rare Genetic Diseases by Small Molecule Allosteric Activators"